Correlation Between ACELYRIN, INC and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both ACELYRIN, INC and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ACELYRIN, INC and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ACELYRIN, INC Common and Molecular Partners AG, you can compare the effects of market volatilities on ACELYRIN, INC and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ACELYRIN, INC with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of ACELYRIN, INC and Molecular Partners.
Diversification Opportunities for ACELYRIN, INC and Molecular Partners
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between ACELYRIN, and Molecular is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding ACELYRIN, INC Common and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and ACELYRIN, INC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ACELYRIN, INC Common are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of ACELYRIN, INC i.e., ACELYRIN, INC and Molecular Partners go up and down completely randomly.
Pair Corralation between ACELYRIN, INC and Molecular Partners
Given the investment horizon of 90 days ACELYRIN, INC Common is expected to under-perform the Molecular Partners. But the stock apears to be less risky and, when comparing its historical volatility, ACELYRIN, INC Common is 1.35 times less risky than Molecular Partners. The stock trades about -0.23 of its potential returns per unit of risk. The Molecular Partners AG is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 615.00 in Molecular Partners AG on August 31, 2024 and sell it today you would lose (32.00) from holding Molecular Partners AG or give up 5.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ACELYRIN, INC Common vs. Molecular Partners AG
Performance |
| Timeline |
| ACELYRIN, INC Common |
| Molecular Partners |
ACELYRIN, INC and Molecular Partners Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ACELYRIN, INC and Molecular Partners
The main advantage of trading using opposite ACELYRIN, INC and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ACELYRIN, INC position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.| ACELYRIN, INC vs. Inflection Point Acquisition | ACELYRIN, INC vs. Sabre Corpo | ACELYRIN, INC vs. Griffon | ACELYRIN, INC vs. Sapiens International |
| Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |